Vı́t Zikán

1.1k total citations · 1 hit paper
31 papers, 755 citations indexed

About

Vı́t Zikán is a scholar working on Orthopedics and Sports Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Vı́t Zikán has authored 31 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Orthopedics and Sports Medicine, 14 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Vı́t Zikán's work include Bone health and osteoporosis research (16 papers), Bone health and treatments (13 papers) and Bone Metabolism and Diseases (10 papers). Vı́t Zikán is often cited by papers focused on Bone health and osteoporosis research (16 papers), Bone health and treatments (13 papers) and Bone Metabolism and Diseases (10 papers). Vı́t Zikán collaborates with scholars based in Czechia, United States and Slovakia. Vı́t Zikán's co-authors include J Štěpán, Ivan Raška, Piet Geusens, Cristiano A. F. Zerbini, Fernando Marín, Péter L. Lakatos, Éric Lespessailles, A. Bagur, J.J. Body and Susan L. Greenspan and has published in prestigious journals such as The Lancet, Bone and Clinica Chimica Acta.

In The Last Decade

Vı́t Zikán

30 papers receiving 740 citations

Hit Papers

Effects of teriparatide and risedronate on new fractures ... 2017 2026 2020 2023 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vı́t Zikán Czechia 14 445 268 260 151 141 31 755
Ping Shao China 10 224 0.5× 163 0.6× 134 0.5× 132 0.9× 110 0.8× 23 798
Ian Reid New Zealand 4 478 1.1× 184 0.7× 200 0.8× 78 0.5× 221 1.6× 6 738
Osamu Chaki Japan 13 472 1.1× 307 1.1× 302 1.2× 78 0.5× 148 1.0× 22 834
F. Zucchi Italy 12 273 0.6× 119 0.4× 166 0.6× 124 0.8× 83 0.6× 21 740
J. A. Clowes United Kingdom 6 302 0.7× 127 0.5× 158 0.6× 205 1.4× 66 0.5× 7 512
S. Adami Italy 13 446 1.0× 205 0.8× 293 1.1× 104 0.7× 138 1.0× 25 934
Xi‐Yu Wu China 13 326 0.7× 212 0.8× 114 0.4× 145 1.0× 49 0.3× 33 581
M Luengo Spain 7 355 0.8× 140 0.5× 178 0.7× 70 0.5× 108 0.8× 8 530
Stephan Scharla Germany 15 360 0.8× 289 1.1× 226 0.9× 64 0.4× 235 1.7× 49 980
Deog‐Yoon Kim South Korea 15 381 0.9× 113 0.4× 355 1.4× 78 0.5× 44 0.3× 47 711

Countries citing papers authored by Vı́t Zikán

Since Specialization
Citations

This map shows the geographic impact of Vı́t Zikán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vı́t Zikán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vı́t Zikán more than expected).

Fields of papers citing papers by Vı́t Zikán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vı́t Zikán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vı́t Zikán. The network helps show where Vı́t Zikán may publish in the future.

Co-authorship network of co-authors of Vı́t Zikán

This figure shows the co-authorship network connecting the top 25 collaborators of Vı́t Zikán. A scholar is included among the top collaborators of Vı́t Zikán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vı́t Zikán. Vı́t Zikán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zikán, Vı́t. (2023). Osteoporosis in adults in clinical practice (1): diagnosis and differential diagnosis. Vnitřní lékařství. 69(4). E4–E15.
2.
Kushnir, Igal, et al.. (2023). Recurrent Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1 Syndrome. Physiological Research. 72(S4). S423–S427. 2 indexed citations
3.
Raška, Ivan, Pavel Abaffy, Radek Šindelka, et al.. (2023). Human bone marrow stromal cells: the impact of anticoagulants on stem cell properties. Frontiers in Cell and Developmental Biology. 11. 1255823–1255823. 2 indexed citations
4.
Zikán, Vı́t, et al.. (2022). Tumor induced osteomalacia - A long way toward correct diagnosis and management. Bone Reports. 16. 101180–101180. 3 indexed citations
5.
Raška, Ivan, et al.. (2017). Prevalence and Risk Factors of Osteoporosis in Postmenopausal Women with Type 2 Diabetes Mellitus. Central European Journal of Public Health. 25(1). 3–10. 29 indexed citations
6.
Kendler, David L., Fernando Marín, Cristiano A. F. Zerbini, et al.. (2017). Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. The Lancet. 391(10117). 230–240. 382 indexed citations breakdown →
7.
Raška, Ivan, et al.. (2017). Body Composition is Associated With Bone and Glucose Metabolism in Postmenopausal Women With Type 2 Diabetes Mellitus. Physiological Research. 66(1). 99–111. 9 indexed citations
8.
Raška, Ivan, et al.. (2016). High Prevalence of Hypovitaminosis D in Postmenopausal Women with Type 2 Diabetes Mellitus. Prague Medical Report. 117(1). 5–17. 11 indexed citations
9.
Michalská, Dana, et al.. (2012). Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis. Osteoporosis International. 23(12). 2885–2891. 39 indexed citations
10.
Kaválková, Petra, I Dostálová, D Haluzíková, et al.. (2012). Preadipocyte Factor-1 Concentrations in Patients With Anorexia Nervosa: the Influence of Partial Realimentation. Physiological Research. 61(2). 153–159. 7 indexed citations
11.
Zikán, Vı́t, Michaela Týblová, Ivan Raška, et al.. (2012). Bone Mineral Density and Body Composition in Men With Multiple Sclerosis Chronically Treated With Low-Dose Glucocorticoids. Physiological Research. 61(4). 405–417. 14 indexed citations
12.
Zikán, Vı́t, et al.. (2011). The effect of timing of teriparatide treatment on the circadian rhythm of bone turnover in postmenopausal osteoporosis. European Journal of Endocrinology. 164(4). 643–648. 34 indexed citations
13.
Marek, J, Václav Hána, Martin Matoulek, et al.. (2010). Plasma concentrations of adipocyte fatty acid binding protein in patients with Cushing's syndrome. Physiological Research. 59(6). 963–971. 6 indexed citations
14.
Marek, J, Václav Hána, Martin Matoulek, et al.. (2010). Plasma Concentrations of Fibroblast Growth Factors 21 and 19in Patients with Cushing's Syndrome. Physiological Research. 59(3). 415–422. 26 indexed citations
16.
Zikán, Vı́t & J Štěpán. (2004). Diminished Acute Response of Osteoclasts to Calcium Load in Thyroidectomized Patients. Calcified Tissue International. 74(4). 377–381. 1 indexed citations
17.
Štěpán, J, Eva Havrdová, Michaela Týblová, et al.. (2004). Markers of bone remodeling predict rate of bone loss in multiple sclerosis patients treated with low dose glucocorticoids. Clinica Chimica Acta. 348(1-2). 147–154. 21 indexed citations
18.
Zikán, Vı́t & J Štěpán. (2002). Plasma type 1 collagen cross-linked C-telopeptide: a sensitive marker of acute effects of salmon calcitonin on bone resorption. Clinica Chimica Acta. 316(1-2). 63–69. 10 indexed citations
19.
Zikán, Vı́t, T Haas, & J Štěpán. (2001). Acute Effects in Healthy Women of Oral Calcium on the Calcium-Parathyroid Axis and Bone Resorption as Assessed by Serum b-CrossLaps. Calcified Tissue International. 68(6). 352–357. 27 indexed citations
20.
Zikán, Vı́t, Petr Roubal, T Haas, et al.. (2001). Acute effects of calcium carbonate and milk on the calcium-parathyroid axis and bone resorption in healthy women.. 131–140. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026